Deutsch English Français

Contact

EP1664086

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1664086

EP1664086 - CHROMATOGRAPHIC SEPARATION OF THERAPEUTIC POLYPEPTIDES [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 03.09.2010 Database last updated on 16.09.2024
Most recent event Tooltip	14.09.2012	Lapse of the patent in a contracting state New state(s): HU	published on 17.10.2012 [2012/42]
Applicant(s)	For all designated states Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street Emeryville, CA 94608-2912 / US
	[2008/52]
Former [2007/04]	For all designated states Novartis Vaccines and Diagnostics, Inc. 4560 Horton Street Emeryville, CA 94608 / US
Former [2006/23]	For all designated states CHIRON CORPORATION 4560 Horton Street Emeryville, CA 94608-2912 / US
Inventor(s)	01 / RIQUELME, Patricio T., Chiron Corporation P.O. Box 8097 Emeryville, CA 94662-8097 / US
	02 / VICTA, Corazon Terciano, Chiron Corporation P.O. Box 8097 Emeryville, CA 94662-8097 / US
	03 / CROSIER, Walter Joseph, Chiron Corporation P.O. Box 8097 Emeryville, CA 94662-8097 / US
	04 / WENDELL, John Tharin, Chiron Corporation P.O. Box 8097 Emeryville, CA 94662-8097 / US
	[2006/23]
Representative(s)	Marshall, Cameron John, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2006/23]	Marshall, Cameron John, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB
Application number, filing date	04783837.0	09.09.2004
	[2006/23]
	WO2004US29774
Priority number, date	US20030501610P	09.09.2003 Original published format: US 501610 P
	[2006/23]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2005023840
	Date:	17.03.2005
	Language:	EN
	[2005/11]
	Type:	A1 Application with search report
	No.:	EP1664086
	Date:	07.06.2006
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 17.03.2005 takes the place of the publication of the European patent application.
	[2006/23]
	Type:	B1 Patent specification
	No.:	EP1664086
	Date:	28.10.2009
	Language:	EN
	[2009/44]
Search report(s)	International search report - published on:	EP	17.03.2005
Classification	IPC:	C07K1/16	[2006/23]
	CPC:	C07K14/565 (EP,US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/23]
Extension states	AL	Not yet paid
	HR	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	CHROMATOGRAPHISCHE AUFTRENNUNG THERAPEUTISCHER POLYPEPTIDE	[2006/23]
	English:	CHROMATOGRAPHIC SEPARATION OF THERAPEUTIC POLYPEPTIDES	[2006/23]
	French:	SEPARATION CHROMATOGRAPHIQUE DE POLYPEPTIDES THERAPEUTIQUES	[2006/23]
Entry into regional phase	10.03.2006	National basic fee paid
	10.03.2006	Designation fee(s) paid
	10.03.2006	Examination fee paid
Examination procedure	10.03.2006	Amendment by applicant (claims and/or description)
	10.03.2006	Examination requested [2006/23]
	09.03.2007	Despatch of a communication from the examining division (Time limit: M06)
	19.09.2007	Reply to a communication from the examining division
	08.10.2007	Despatch of a communication from the examining division (Time limit: M04)
	15.02.2008	Reply to a communication from the examining division
	01.04.2008	Despatch of a communication from the examining division (Time limit: M06)
	01.09.2008	Reply to a communication from the examining division
	03.12.2008	Communication of intention to grant the patent
	19.05.2009	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
	29.07.2009	Fee for grant paid
	29.07.2009	Fee for publishing/printing paid
Opposition(s)	29.07.2010	No opposition filed within time limit [2010/40]
Request for further processing for:	The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
	29.07.2009	Request for further processing filed
	29.07.2009	Full payment received (date of receipt of payment)
Fees paid	Renewal fee
	10.03.2006	Renewal fee patent year 03
	10.12.2007	Renewal fee patent year 04
	31.03.2008	Renewal fee patent year 05
	11.09.2009	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	30.09.2007	04 M06 Fee paid on 10.12.2007
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	28.10.2009
	CZ	28.10.2009
	DK	28.10.2009
	EE	28.10.2009
	FI	28.10.2009
	RO	28.10.2009
	SE	28.10.2009
	SI	28.10.2009
	SK	28.10.2009
	BG	28.01.2010
	HU	29.04.2010
	[2012/42]
Former [2010/39]	CY	28.10.2009
	CZ	28.10.2009
	DK	28.10.2009
	EE	28.10.2009
	FI	28.10.2009
	RO	28.10.2009
	SE	28.10.2009
	SI	28.10.2009
	SK	28.10.2009
	BG	28.01.2010
Former [2010/36]	CY	28.10.2009
	CZ	28.10.2009
	DK	28.10.2009
	EE	28.10.2009
	FI	28.10.2009
	RO	28.10.2009
	SE	28.10.2009
	SI	28.10.2009
	BG	28.01.2010
Former [2010/25]	CY	28.10.2009
	FI	28.10.2009
	SE	28.10.2009
	SI	28.10.2009
Former [2010/23]	FI	28.10.2009
	SE	28.10.2009
	SI	28.10.2009
Former [2010/22]	FI	28.10.2009
	SE	28.10.2009
Cited in	International search	[Y]EP0529300 (BIOFERON BIOCHEM SUBSTANZ [DE]) [Y] 1-35* see p. 7, l. 18-38; claims *;
		[X] - RUSSELL-HARDE D ET AL, "THE USE OF ZWITTERGENT 3-14 IN THE PURIFICATION OF RECOMBINANT HUMAN INTERFERON-BETA SER17 (BETASERON)", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, MARY ANN LIEBERT, NEW YORK, NY, US, (1995), vol. 15, no. 1, ISSN 1079-9907, pages 31 - 37, XP008014279 [X] 1-35 * see Figure 2 *
		[Y] - RUNKEL L ET AL, "Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-Beta (IFN-Beta)", PHARMACEUTICAL RESEARCH, NEW YORK, NY, US, (1998), vol. 15, no. 4, ISSN 0724-8741, pages 641 - 649, XP002271902 [Y] 1-35 * see abstract, p. 642, right col. sec. para., Fig. 5 * DOI: http://dx.doi.org/10.1023/A:1011974512425

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p